Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Liraglutide Market 2018, Forecast to 2023

Publisher Name :
Date: 11-Jun-2018
No. of pages: 134

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Scope of the Report:

This report focuses on the Liraglutide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.

In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.

The application of Liraglutide

Liraglutide for the treatment of type 2 diabetes mellitus

Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in 'Type 2 diabetes: the management of type 2 diabetes'

Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.

Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.

The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.

Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.

The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.

The worldwide market for Liraglutide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- HEC Pharm

- Bachem

- Bharat Pharmaceuticals

- Kingpep Biotechnology

- Shenzhen JYMed Technology

- Wuxi Asiapeptide

- AmbioPharm

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Pills

- Liquid

Market Segment by Applications, can be divided into

- Hospital

- Drug Store

There are 15 Chapters to deeply display the global Liraglutide market.

Chapter 1, to describe Liraglutide Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Liraglutide, with sales, revenue, and price of Liraglutide, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Liraglutide, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Liraglutide market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Liraglutide sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Liraglutide Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Liraglutide Introduction
1.2 Market Analysis by Type
1.2.1 Pills
1.2.2 Liquid
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Drug Store
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 HEC Pharm
2.1.1 Business Overview
2.1.1.1 HEC Pharm Description
2.1.1.2 HEC Pharm Headquarter, Main Business and Finance Overview
2.1.2 HEC Pharm Liraglutide Product Introduction
2.1.2.1 Liraglutide Production Bases, Sales Regions and Major Competitors
2.1.2.2 Liraglutide Product Information
2.1.3 HEC Pharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 HEC Pharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global HEC Pharm Liraglutide Market Share in 2017
2.2 Bachem
2.2.1 Business Overview
2.2.1.1 Bachem Description
2.2.1.2 Bachem Headquarter, Main Business and Finance Overview
2.2.2 Bachem Liraglutide Product Introduction
2.2.2.1 Liraglutide Production Bases, Sales Regions and Major Competitors
2.2.2.2 Liraglutide Product Information
2.2.3 Bachem Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Bachem Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Bachem Liraglutide Market Share in 2017
2.3 Bharat Pharmaceuticals
2.3.1 Business Overview
2.3.1.1 Bharat Pharmaceuticals Description
2.3.1.2 Bharat Pharmaceuticals Headquarter, Main Business and Finance Overview
2.3.2 Bharat Pharmaceuticals Liraglutide Product Introduction
2.3.2.1 Liraglutide Production Bases, Sales Regions and Major Competitors
2.3.2.2 Liraglutide Product Information
2.3.3 Bharat Pharmaceuticals Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Bharat Pharmaceuticals Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Bharat Pharmaceuticals Liraglutide Market Share in 2017
2.4 Kingpep Biotechnology
2.4.1 Business Overview
2.4.1.1 Kingpep Biotechnology Description
2.4.1.2 Kingpep Biotechnology Headquarter, Main Business and Finance Overview
2.4.2 Kingpep Biotechnology Liraglutide Product Introduction
2.4.2.1 Liraglutide Production Bases, Sales Regions and Major Competitors
2.4.2.2 Liraglutide Product Information
2.4.3 Kingpep Biotechnology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Kingpep Biotechnology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Kingpep Biotechnology Liraglutide Market Share in 2017
2.5 Shenzhen JYMed Technology
2.5.1 Business Overview
2.5.1.1 Shenzhen JYMed Technology Description
2.5.1.2 Shenzhen JYMed Technology Headquarter, Main Business and Finance Overview
2.5.2 Shenzhen JYMed Technology Liraglutide Product Introduction
2.5.2.1 Liraglutide Production Bases, Sales Regions and Major Competitors
2.5.2.2 Liraglutide Product Information
2.5.3 Shenzhen JYMed Technology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Shenzhen JYMed Technology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Shenzhen JYMed Technology Liraglutide Market Share in 2017
2.6 Wuxi Asiapeptide
2.6.1 Business Overview
2.6.1.1 Wuxi Asiapeptide Description
2.6.1.2 Wuxi Asiapeptide Headquarter, Main Business and Finance Overview
2.6.2 Wuxi Asiapeptide Liraglutide Product Introduction
2.6.2.1 Liraglutide Production Bases, Sales Regions and Major Competitors
2.6.2.2 Liraglutide Product Information
2.6.3 Wuxi Asiapeptide Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Wuxi Asiapeptide Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Wuxi Asiapeptide Liraglutide Market Share in 2017
2.7 AmbioPharm
2.7.1 Business Overview
2.7.1.1 AmbioPharm Description
2.7.1.2 AmbioPharm Headquarter, Main Business and Finance Overview
2.7.2 AmbioPharm Liraglutide Product Introduction
2.7.2.1 Liraglutide Production Bases, Sales Regions and Major Competitors
2.7.2.2 Liraglutide Product Information
2.7.3 AmbioPharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 AmbioPharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global AmbioPharm Liraglutide Market Share in 2017
3 Global Liraglutide Market Competition, by Manufacturer
3.1 Global Liraglutide Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Liraglutide Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Liraglutide Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Liraglutide Manufacturer Market Share in 2017
3.4.2 Top 5 Liraglutide Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Liraglutide Market Analysis by Regions
4.1 Global Liraglutide Sales, Revenue and Market Share by Regions
4.1.1 Global Liraglutide Sales by Regions (2013-2018)
4.1.2 Global Liraglutide Revenue by Regions (2013-2018)
4.2 North America Liraglutide Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Liraglutide Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Liraglutide Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Liraglutide Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Liraglutide Sales, Revenue and Growth Rate (2013-2018)
5 North America Liraglutide by Countries, Type, Application and Manufacturers
5.1 North America Liraglutide Sales, Revenue and Market Share by Countries
5.1.1 North America Liraglutide Sales by Countries (2013-2018)
5.1.2 North America Liraglutide Revenue by Countries (2013-2018)
5.1.3 United States Liraglutide Sales and Growth Rate (2013-2018)
5.1.4 Canada Liraglutide Sales and Growth Rate (2013-2018)
5.1.5 Mexico Liraglutide Sales and Growth Rate (2013-2018)
5.2 North America Liraglutide Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Liraglutide Sales by Manufacturers (2016-2017)
5.2.2 North America Liraglutide Revenue by Manufacturers (2016-2017)
5.3 North America Liraglutide Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Liraglutide Sales and Sales Share by Type (2013-2018)
5.3.2 North America Liraglutide Revenue and Revenue Share by Type (2013-2018)
5.4 North America Liraglutide Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Liraglutide Sales and Sales Share by Application (2013-2018)
5.4.2 North America Liraglutide Revenue and Revenue Share by Application (2013-2018)
6 Europe Liraglutide by Countries, Type, Application and Manufacturers
6.1 Europe Liraglutide Sales, Revenue and Market Share by Countries
6.1.1 Europe Liraglutide Sales by Countries (2013-2018)
6.1.2 Europe Liraglutide Revenue by Countries (2013-2018)
6.1.3 Germany Liraglutide Sales and Growth Rate (2013-2018)
6.1.4 UK Liraglutide Sales and Growth Rate (2013-2018)
6.1.5 France Liraglutide Sales and Growth Rate (2013-2018)
6.1.6 Russia Liraglutide Sales and Growth Rate (2013-2018)
6.1.7 Italy Liraglutide Sales and Growth Rate (2013-2018)
6.2 Europe Liraglutide Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Liraglutide Sales by Manufacturers (2016-2017)
6.2.2 Europe Liraglutide Revenue by Manufacturers (2016-2017)
6.3 Europe Liraglutide Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Liraglutide Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Liraglutide Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Liraglutide Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Liraglutide Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Liraglutide Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Liraglutide by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Liraglutide Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Liraglutide Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Liraglutide Revenue by Countries (2013-2018)
7.1.3 China Liraglutide Sales and Growth Rate (2013-2018)
7.1.4 Japan Liraglutide Sales and Growth Rate (2013-2018)
7.1.5 Korea Liraglutide Sales and Growth Rate (2013-2018)
7.1.6 India Liraglutide Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Liraglutide Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Liraglutide Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Liraglutide Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Liraglutide Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Liraglutide Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Liraglutide Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Liraglutide Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Liraglutide Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Liraglutide Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Liraglutide Revenue and Revenue Share by Application (2013-2018)
8 South America Liraglutide by Countries, Type, Application and Manufacturers
8.1 South America Liraglutide Sales, Revenue and Market Share by Countries
8.1.1 South America Liraglutide Sales by Countries (2013-2018)
8.1.2 South America Liraglutide Revenue by Countries (2013-2018)
8.1.3 Brazil Liraglutide Sales and Growth Rate (2013-2018)
8.1.4 Argentina Liraglutide Sales and Growth Rate (2013-2018)
8.1.5 Colombia Liraglutide Sales and Growth Rate (2013-2018)
8.2 South America Liraglutide Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Liraglutide Sales by Manufacturers (2016-2017)
8.2.2 South America Liraglutide Revenue by Manufacturers (2016-2017)
8.3 South America Liraglutide Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Liraglutide Sales and Sales Share by Type (2013-2018)
8.3.2 South America Liraglutide Revenue and Revenue Share by Type (2013-2018)
8.4 South America Liraglutide Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Liraglutide Sales and Sales Share by Application (2013-2018)
8.4.2 South America Liraglutide Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Liraglutide by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Liraglutide Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Liraglutide Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Liraglutide Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Liraglutide Sales and Growth Rate (2013-2018)
9.1.4 UAE Liraglutide Sales and Growth Rate (2013-2018)
9.1.5 Egypt Liraglutide Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Liraglutide Sales and Growth Rate (2013-2018)
9.1.7 South Africa Liraglutide Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Liraglutide Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Liraglutide Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Liraglutide Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Liraglutide Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Liraglutide Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Liraglutide Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Liraglutide Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Liraglutide Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Liraglutide Revenue and Revenue Share by Application (2013-2018)
10 Global Liraglutide Market Segment by Type
10.1 Global Liraglutide Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Liraglutide Sales and Market Share by Type (2013-2018)
10.1.2 Global Liraglutide Revenue and Market Share by Type (2013-2018)
10.2 Pills Sales Growth and Price
10.2.1 Global Pills Sales Growth (2013-2018)
10.2.2 Global Pills Price (2013-2018)
10.3 Liquid Sales Growth and Price
10.3.1 Global Liquid Sales Growth (2013-2018)
10.3.2 Global Liquid Price (2013-2018)
11 Global Liraglutide Market Segment by Application
11.1 Global Liraglutide Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Drug Store Sales Growth (2013-2018)
12 Liraglutide Market Forecast (2018-2023)
12.1 Global Liraglutide Sales, Revenue and Growth Rate (2018-2023)
12.2 Liraglutide Market Forecast by Regions (2018-2023)
12.2.1 North America Liraglutide Market Forecast (2018-2023)
12.2.2 Europe Liraglutide Market Forecast (2018-2023)
12.2.3 Asia-Pacific Liraglutide Market Forecast (2018-2023)
12.2.4 South America Liraglutide Market Forecast (2018-2023)
12.2.5 Middle East and Africa Liraglutide Market Forecast (2018-2023)
12.3 Liraglutide Market Forecast by Type (2018-2023)
12.3.1 Global Liraglutide Sales Forecast by Type (2018-2023)
12.3.2 Global Liraglutide Market Share Forecast by Type (2018-2023)
12.4 Liraglutide Market Forecast by Application (2018-2023)
12.4.1 Global Liraglutide Sales Forecast by Application (2018-2023)
12.4.2 Global Liraglutide Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Liraglutide Picture
Table Product Specifications of Liraglutide
Figure Global Liraglutide CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Liraglutide CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Liraglutide by Types in 2017
Figure Pills Picture
Table Major Manufacturers of Pills
Figure Liquid Picture
Table Major Manufacturers of Liquid
Figure Liraglutide Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Drug Store Picture
Figure United States Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure France Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure UK Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure China Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure India Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Table HEC Pharm Headquarter, Established, Main Business and Finance Overview (2017)
Table HEC Pharm Liraglutide Production Bases, Sales Regions and Major Competitors
Table HEC Pharm Liraglutide Product
Table HEC Pharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global HEC Pharm Liraglutide Sales Market Share in 2017
Figure Global HEC Pharm Liraglutide Revenue Market Share in 2017
Table Bachem Headquarter, Established, Main Business and Finance Overview (2017)
Table Bachem Liraglutide Production Bases, Sales Regions and Major Competitors
Table Bachem Liraglutide Product
Table Bachem Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bachem Liraglutide Sales Market Share in 2017
Figure Global Bachem Liraglutide Revenue Market Share in 2017
Table Bharat Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Bharat Pharmaceuticals Liraglutide Production Bases, Sales Regions and Major Competitors
Table Bharat Pharmaceuticals Liraglutide Product
Table Bharat Pharmaceuticals Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bharat Pharmaceuticals Liraglutide Sales Market Share in 2017
Figure Global Bharat Pharmaceuticals Liraglutide Revenue Market Share in 2017
Table Kingpep Biotechnology Headquarter, Established, Main Business and Finance Overview (2017)
Table Kingpep Biotechnology Liraglutide Production Bases, Sales Regions and Major Competitors
Table Kingpep Biotechnology Liraglutide Product
Table Kingpep Biotechnology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Kingpep Biotechnology Liraglutide Sales Market Share in 2017
Figure Global Kingpep Biotechnology Liraglutide Revenue Market Share in 2017
Table Shenzhen JYMed Technology Headquarter, Established, Main Business and Finance Overview (2017)
Table Shenzhen JYMed Technology Liraglutide Production Bases, Sales Regions and Major Competitors
Table Shenzhen JYMed Technology Liraglutide Product
Table Shenzhen JYMed Technology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shenzhen JYMed Technology Liraglutide Sales Market Share in 2017
Figure Global Shenzhen JYMed Technology Liraglutide Revenue Market Share in 2017
Table Wuxi Asiapeptide Headquarter, Established, Main Business and Finance Overview (2017)
Table Wuxi Asiapeptide Liraglutide Production Bases, Sales Regions and Major Competitors
Table Wuxi Asiapeptide Liraglutide Product
Table Wuxi Asiapeptide Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Wuxi Asiapeptide Liraglutide Sales Market Share in 2017
Figure Global Wuxi Asiapeptide Liraglutide Revenue Market Share in 2017
Table AmbioPharm Headquarter, Established, Main Business and Finance Overview (2017)
Table AmbioPharm Liraglutide Production Bases, Sales Regions and Major Competitors
Table AmbioPharm Liraglutide Product
Table AmbioPharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AmbioPharm Liraglutide Sales Market Share in 2017
Figure Global AmbioPharm Liraglutide Revenue Market Share in 2017
Table Global Liraglutide Sales by Manufacturer (2016-2017)
Figure Global Liraglutide Sales Market Share by Manufacturer in 2016
Figure Global Liraglutide Sales Market Share by Manufacturer in 2017
Table Global Liraglutide Revenue by Manufacturer (2016-2017)
Figure Global Liraglutide Revenue Market Share by Manufacturer in 2016
Figure Global Liraglutide Revenue Market Share by Manufacturer in 2017
Table Global Liraglutide Price by Manufacturer (2016-2017)
Figure Top 3 Liraglutide Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Liraglutide Manufacturer (Revenue) Market Share in 2017
Figure Global Liraglutide Sales and Growth Rate (2013-2018)
Figure Global Liraglutide Revenue and Growth Rate (2013-2018)
Table Global Liraglutide Sales by Regions (2013-2018)
Table Global Liraglutide Sales Market Share by Regions (2013-2018)
Table Global Liraglutide Revenue by Regions (2013-2018)
Figure Global Liraglutide Revenue Market Share by Regions in 2013
Figure Global Liraglutide Revenue Market Share by Regions in 2017
Figure North America Liraglutide Sales and Growth Rate (2013-2018)
Figure North America Liraglutide Revenue and Growth Rate (2013-2018)
Figure Europe Liraglutide Sales and Growth Rate (2013-2018)
Figure Europe Liraglutide Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Liraglutide Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Liraglutide Revenue and Growth Rate (2013-2018)
Figure South America Liraglutide Sales and Growth Rate (2013-2018)
Figure South America Liraglutide Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Liraglutide Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Liraglutide Revenue and Growth Rate (2013-2018)
Figure North America Liraglutide Revenue and Growth Rate (2013-2018)
Table North America Liraglutide Sales by Countries (2013-2018)
Table North America Liraglutide Sales Market Share by Countries (2013-2018)
Figure North America Liraglutide Sales Market Share by Countries in 2013
Figure North America Liraglutide Sales Market Share by Countries in 2017
Table North America Liraglutide Revenue by Countries (2013-2018)
Table North America Liraglutide Revenue Market Share by Countries (2013-2018)
Figure North America Liraglutide Revenue Market Share by Countries in 2013
Figure North America Liraglutide Revenue Market Share by Countries in 2017
Figure United States Liraglutide Sales and Growth Rate (2013-2018)
Figure Canada Liraglutide Sales and Growth Rate (2013-2018)
Figure Mexico Liraglutide Sales and Growth Rate (2013-2018)
Table North America Liraglutide Sales by Manufacturer (2016-2017)
Figure North America Liraglutide Sales Market Share by Manufacturer in 2016
Figure North America Liraglutide Sales Market Share by Manufacturer in 2017
Table North America Liraglutide Revenue by Manufacturer (2016-2017)
Figure North America Liraglutide Revenue Market Share by Manufacturer in 2016
Figure North America Liraglutide Revenue Market Share by Manufacturer in 2017
Table North America Liraglutide Sales by Type (2013-2018)
Table North America Liraglutide Sales Share by Type (2013-2018)
Table North America Liraglutide Revenue by Type (2013-2018)
Table North America Liraglutide Revenue Share by Type (2013-2018)
Table North America Liraglutide Sales by Application (2013-2018)
Table North America Liraglutide Sales Share by Application (2013-2018)
Table North America Liraglutide Revenue by Application (2013-2018)
Table North America Liraglutide Revenue Share by Application (2013-2018)
Figure Europe Liraglutide Revenue and Growth Rate (2013-2018)
Table Europe Liraglutide Sales by Countries (2013-2018)
Table Europe Liraglutide Sales Market Share by Countries (2013-2018)
Table Europe Liraglutide Revenue by Countries (2013-2018)
Figure Europe Liraglutide Revenue Market Share by Countries in 2016
Figure Europe Liraglutide Revenue Market Share by Countries in 2017
Figure Germany Liraglutide Sales and Growth Rate (2013-2018)
Figure UK Liraglutide Sales and Growth Rate (2013-2018)
Figure France Liraglutide Sales and Growth Rate (2013-2018)
Figure Russia Liraglutide Sales and Growth Rate (2013-2018)
Figure Italy Liraglutide Sales and Growth Rate (2013-2018)
Table Europe Liraglutide Sales by Manufacturer (2016-2017)
Figure Europe Liraglutide Sales Market Share by Manufacturer in 2016
Figure Europe Liraglutide Sales Market Share by Manufacturer in 2017
Table Europe Liraglutide Revenue by Manufacturer (2016-2017)
Figure Europe Liraglutide Revenue Market Share by Manufacturer in 2016
Figure Europe Liraglutide Revenue Market Share by Manufacturer in 2017
Table Europe Liraglutide Sales by Type (2013-2018)
Table Europe Liraglutide Sales Share by Type (2013-2018)
Table Europe Liraglutide Revenue by Type (2013-2018)
Table Europe Liraglutide Revenue Share by Type (2013-2018)
Table Europe Liraglutide Sales by Application (2013-2018)
Table Europe Liraglutide Sales Share by Application (2013-2018)
Table Europe Liraglutide Revenue by Application (2013-2018)
Table Europe Liraglutide Revenue Share by Application (2013-2018)
Figure Asia-Pacific Liraglutide Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Liraglutide Sales by Countries (2013-2018)
Table Asia-Pacific Liraglutide Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Liraglutide Sales Market Share by Countries 2017
Table Asia-Pacific Liraglutide Revenue by Countries (2013-2018)
Figure Asia-Pacific Liraglutide Revenue Market Share by Countries 2017
Figure China Liraglutide Sales and Growth Rate (2013-2018)
Figure Japan Liraglutide Sales and Growth Rate (2013-2018)
Figure Korea Liraglutide Sales and Growth Rate (2013-2018)
Figure India Liraglutide Sales and Growth Rate (2013-2018)
Figure Southeast Asia Liraglutide Sales and Growth Rate (2013-2018)
Table Asia-Pacific Liraglutide Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Liraglutide Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Liraglutide Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Liraglutide Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Liraglutide Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Liraglutide Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Liraglutide Sales by Type (2013-2018)
Table Asia-Pacific Liraglutide Sales Share by Type (2013-2018)
Table Asia-Pacific Liraglutide Revenue by Type (2013-2018)
Table Asia-Pacific Liraglutide Revenue Share by Type (2013-2018)
Table Asia-Pacific Liraglutide Sales by Application (2013-2018)
Table Asia-Pacific Liraglutide Sales Share by Application (2013-2018)
Table Asia-Pacific Liraglutide Revenue by Application (2013-2018)
Table Asia-Pacific Liraglutide Revenue Share by Application (2013-2018)
Figure South America Liraglutide Revenue and Growth Rate (2013-2018)
Table South America Liraglutide Sales by Countries (2013-2018)
Table South America Liraglutide Sales Market Share by Countries (2013-2018)
Figure South America Liraglutide Sales Market Share by Countries in 2017
Table South America Liraglutide Revenue by Countries (2013-2018)
Table South America Liraglutide Revenue Market Share by Countries (2013-2018)
Figure South America Liraglutide Revenue Market Share by Countries in 2017
Figure Brazil Liraglutide Sales and Growth Rate (2013-2018)
Figure Argentina Liraglutide Sales and Growth Rate (2013-2018)
Figure Colombia Liraglutide Sales and Growth Rate (2013-2018)
Table South America Liraglutide Sales by Manufacturer (2016-2017)
Figure South America Liraglutide Sales Market Share by Manufacturer in 2016
Figure South America Liraglutide Sales Market Share by Manufacturer in 2017
Table South America Liraglutide Revenue by Manufacturer (2016-2017)
Figure South America Liraglutide Revenue Market Share by Manufacturer in 2016
Figure South America Liraglutide Revenue Market Share by Manufacturer in 2017
Table South America Liraglutide Sales by Type (2013-2018)
Table South America Liraglutide Sales Share by Type (2013-2018)
Table South America Liraglutide Revenue by Type (2013-2018)
Table South America Liraglutide Revenue Share by Type (2013-2018)
Table South America Liraglutide Sales by Application (2013-2018)
Table South America Liraglutide Sales Share by Application (2013-2018)
Table South America Liraglutide Revenue by Application (2013-2018)
Table South America Liraglutide Revenue Share by Application (2013-2018)
Figure Middle East and Africa Liraglutide Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Liraglutide Sales by Countries (2013-2018)
Table Middle East and Africa Liraglutide Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Liraglutide Sales Market Share by Countries in 2017
Table Middle East and Africa Liraglutide Revenue by Countries (2013-2018)
Table Middle East and Africa Liraglutide Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Liraglutide Revenue Market Share by Countries in 2013
Figure Middle East and Africa Liraglutide Revenue Market Share by Countries in 2017
Figure Saudi Arabia Liraglutide Sales and Growth Rate (2013-2018)
Figure UAE Liraglutide Sales and Growth Rate (2013-2018)
Figure Egypt Liraglutide Sales and Growth Rate (2013-2018)
Figure Nigeria Liraglutide Sales and Growth Rate (2013-2018)
Figure South Africa Liraglutide Sales and Growth Rate (2013-2018)
Table Middle East and Africa Liraglutide Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Liraglutide Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Liraglutide Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Liraglutide Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Liraglutide Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Liraglutide Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Liraglutide Sales by Type (2013-2018)
Table Middle East and Africa Liraglutide Sales Share by Type (2013-2018)
Table Middle East and Africa Liraglutide Revenue by Type (2013-2018)
Table Middle East and Africa Liraglutide Revenue Share by Type (2013-2018)
Table Middle East and Africa Liraglutide Sales by Application (2013-2018)
Table Middle East and Africa Liraglutide Sales Share by Application (2013-2018)
Table Middle East and Africa Liraglutide Revenue by Application (2013-2018)
Table Middle East and Africa Liraglutide Revenue Share by Application (2013-2018)
Table Global Liraglutide Sales by Type (2013-2018)
Table Global Liraglutide Sales Share by Type (2013-2018)
Table Global Liraglutide Revenue by Type (2013-2018)
Table Global Liraglutide Revenue Share by Type (2013-2018)
Figure Global Pills Sales Growth (2013-2018)
Figure Global Pills Price (2013-2018)
Figure Global Liquid Sales Growth (2013-2018)
Figure Global Liquid Price (2013-2018)
Table Global Liraglutide Sales by Application (2013-2018)
Table Global Liraglutide Sales Share by Application (2013-2018)
Figure Global Hospital Sales Growth (2013-2018)
Figure Global Drug Store Sales Growth (2013-2018)
Figure Global Liraglutide Sales, Revenue and Growth Rate (2018-2023)
Table Global Liraglutide Sales Forecast by Regions (2018-2023)
Table Global Liraglutide Market Share Forecast by Regions (2018-2023)
Figure North America Sales Liraglutide Market Forecast (2018-2023)
Figure Europe Sales Liraglutide Market Forecast (2018-2023)
Figure Asia-Pacific Sales Liraglutide Market Forecast (2018-2023)
Figure South America Sales Liraglutide Market Forecast (2018-2023)
Figure Middle East and Africa Sales Liraglutide Market Forecast (2018-2023)
Table Global Liraglutide Sales Forecast by Type (2018-2023)
Table Global Liraglutide Market Share Forecast by Type (2018-2023)
Table Global Liraglutide Sales Forecast by Application (2018-2023)
Table Global Liraglutide Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Incretin-Based Drugs Market Growth 2018-2023
    Published: 22-Oct-2018        Price: US 3660 Onwards        Pages: 130
    Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs. ......
  • Global Lixisenatide Market Growth 2018-2023
    Published: 22-Oct-2018        Price: US 3660 Onwards        Pages: 139
    Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of diabetes type II. The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace. Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth. However, number of limited manufacturers and distribution channels is anticipated to imped......
  • Global Human Insulin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 22-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans. Scope of the Report: This report focuses on the Human Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. In 2018, North America is estimated to dominate the global human insulin m......
  • Global Lixisenatide Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 112
    Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of diabetes type II.  The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace. Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth. However, number of limited manufacturers and distribution channels is anticipated to imped......
  • Global Antidiabetic Biguanides Market Insights, Forecast to 2025
    Published: 17-Oct-2018        Price: US 3900 Onwards        Pages: 111
    In 2017, the global Antidiabetic Biguanides market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Antidiabetic Biguanides market based on company, product type, application and key regions. This report studies the global market size of Antidiabetic Biguanides in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & ......
  • Global Antidiabetic Sulphonylureas Market Insights, Forecast to 2025
    Published: 17-Oct-2018        Price: US 3900 Onwards        Pages: 114
    In 2017, the global Antidiabetic Sulphonylureas market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Antidiabetic Sulphonylureas market based on company, product type, application and key regions. This report studies the global market size of Antidiabetic Sulphonylureas in key regions like North America, Europe, Asia Pacific, Central & South America and Mi......
  • Global Antidiabetic SGLT-2 Inhibitor Market Insights, Forecast to 2025
    Published: 17-Oct-2018        Price: US 3900 Onwards        Pages: 117
    In 2017, the global Antidiabetic SGLT-2 Inhibitor market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Antidiabetic SGLT-2 Inhibitor market based on company, product type, application and key regions. This report studies the global market size of Antidiabetic SGLT-2 Inhibitor in key regions like North America, Europe, Asia Pacific, Central & South America ......
  • Global Antidiabetic Thiazolidinediones Market Insights, Forecast to 2025
    Published: 17-Oct-2018        Price: US 3900 Onwards        Pages: 116
    In 2017, the global Antidiabetic Thiazolidinediones market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Antidiabetic Thiazolidinediones market based on company, product type, application and key regions. This report studies the global market size of Antidiabetic Thiazolidinediones in key regions like North America, Europe, Asia Pacific, Central & South Am......
  • 2018-2023 Global Insulin Lispro Consumption Market Report
    Published: 11-Oct-2018        Price: US 6990 Onwards        Pages: 130
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Insulin Lispro market for 2018-2023. Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline in the beta chain of th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs